EHC/LinkedIn
Feb 15, 2026, 10:52
Awareness and Research on Factor V Deficiency Are Critical – EHC
European Haemophilia Consortium (EHC) shared a post on LinkedIn:
“Extremely Rare Bleeding Disorder of the Month: Factor V Deficiency
Nosebleeds that won’t stop. Bruises from nowhere.
Bleeding that just keeps going.
For people with this rare clotting disorder, these aren’t occasional issues—they’re part of life.
The condition can affect anyone at any age, but knowing the signs matters.
Right now, treatment options are limited, which is why awareness and research are so critical.
Want to learn more?
On the ERIN Focus Area page on our EHC Community website, you can find relevant webinars, podcasts, and publications.”
Stay updated with Hemostasis Today.
-
Feb 15, 2026, 10:56Don’t Miss PNH: Clinical Practice From ISTH – Medscape
-
Feb 15, 2026, 10:43Peter Zdziarski: Protecting Patient Data in the Rare Disease Community
-
Feb 15, 2026, 10:31Michiel Voet: The Price Tag of a Whole Blood Strategy
-
Feb 15, 2026, 10:26Sifat Jubaira: K₂-EDTA vs K₃-EDTA – Same Anticoagulant, Very Different Accuracy
-
Feb 15, 2026, 09:29Gevorg Tamamyan: Childhood Cancer is Curable. Inequity Is Not
-
Feb 15, 2026, 07:24Ekaterina Balaian Extends Sincere Gratitude to The Team at The Yeolyan Hematology and Oncology Center
-
Feb 15, 2026, 07:10Brijesh Kumar: Stroke Rehabilitation Needs Scalable and Evidence-Based Models
-
Feb 15, 2026, 06:58Reza Hosseini Ghomi: A New Tool Predicts The Onset of Dementia After Stroke
-
Feb 15, 2026, 06:45Mohamed Rawy: Clinical Pearls of Clopidogrel